Health
Top in hem/onc: Checkpoint inhibitor indications, loneliness of childhood cancer survivors – Healio
Last week, an FDA panel voted against maintaining a gastric cancer indication for pembrolizumab and a hepatocellular carcinoma indication for nivolumab. It was…
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
Last week, an FDA panel voted against maintaining a gastric cancer indication for pembrolizumab and a hepatocellular carcinoma indication for nivolumab. It was the top story in hematology/oncology.
Another top story revealed childhood cancer survivors have an elevated risk for feelings of loneliness due to isolation during their cancer experience….
Continue Reading